SCHEMBL10463523

SCHEMBL10463523

O=C1CCC(c2ccc(NCCCCCCO)cc2)=NN1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.49
LMNA P02545 2/20 0.48
NPY1R P25929 1/20 0.48
NPY2R P49146 1/20 0.48
PDE3B Q13370 10/20 0.47
PDE3A Q14432 9/20 0.46
MAPT P10636 2/20 0.45
PDE4A P27815 3/20 0.44
PDE4B Q07343 3/20 0.44
PDE4C Q08493 3/20 0.44
PDE4D Q08499 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
HRH3 Q9Y5N1 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10465918 0.95 KCNH2 (0.56) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL10474199 0.86 LMNA (0.62) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL10464834 0.80 LMNA (0.50) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL21970671 0.78 KCNH2 (0.61) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL10464942 0.77 LMNA (0.52) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL10463518 0.77 LMNA (0.44) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL10463519 0.77 LMNA (0.44) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL10464826 0.76 LMNA (0.45) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL10464825 0.76 LMNA (0.45) KCNH2SMN1; SMN2LMNANPY1RNPY2R
SCHEMBL10353452 0.75 SMN1; SMN2 (0.81) KCNH2SMN1; SMN2LMNANPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4898865-A FOR CIRCULATORY DISEASES, THROMBOSES BAYER AKTIENGESELLSCHAFT (DE) 1990-02-06 US disclosed
EP-0308608-A1 Substituted nitro-dihydropyridines, process for their preparation and their use BAYER AG (DE) 1989-03-29 EP disclosed